Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study
Núria Gresa‐Arribas(Institució Catalana de Recerca i Estudis Avançats), Josep Dalmau(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Frank Leypoldt(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Amy J. Gleichman(The Ohio State University), Myrna R. Rosenfeld(University of Pennsylvania), Maarten J. Titulaer(Erasmus MC), Lindsey McCracken(Hospital of the University of Pennsylvania), Abiguei Torrents(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Rita J. Balice‐Gordon(MC2 Therapeutics (Denmark)), David R. Lynch(Children's Hospital of Philadelphia), Esther Aguilar(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Francesc Graus(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)
Cited by 1,284
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
|The Lancet Neurology|2008|3.5k
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
|The Lancet Neurology|2013|3.1k
Paraneoplastic anti– <i>N</i> ‐methyl‐ <scp>D</scp> ‐aspartate receptor encephalitis associated with ovarian teratoma
|Annals of Neurology|2007|2.5k
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
|The Lancet Neurology|2010|2.4k